A recent study has noted a marked increase in the number of reports of serious adverse drug events to the US FDA in the past few years. However, caution in drawing broad conclusions from data on drug safety seems advisable until stronger data can be obtained.
引用
收藏
页码:767 / 767
相关论文
共 3 条
[1]
Moore TJ(2007)undefined Arch. Intern. Med. 167 1752-1759